Results 201 to 210 of about 12,042,484 (342)

Delays in diagnosis and treatment of ATTR cardiac amyloidosis: A real‐world data analysis

ESC Heart Failure, EarlyView.
Abstract Aims and Background Cardiac amyloidosis leads to functional cardiac impairment and heart failure. Transthyretin amyloid cardiomyopathy (ATTR‐CM) is the most common form. After initial suspicion, diagnosis involves imaging techniques, biopsy and genetic tests, prompting transthyretin stabilizer therapy to slow disease progression.
Julia Vogel, Sophia Jura, Stephan Settelmeier, Florian Buehning, Tobias Lerchner, Alexander Carpinteiro, Tienush Rassaf, Lars Michel   +7 more
wiley   +1 more source

Troponin-T as predictor of mortality in patients attending the emergency department with atrial fibrillation. [PDF]

BMC Cardiovasc Disord
Celik S, Eriksson LB, Hytting J, Waldemar A, Mallios P, Berggren A, Oscarsson E, Digerfeldt C, Wijkman M, Hubbert L.   +9 more
europepmc   +1 more source

Identification and Characterization of <i>Troponin T</i> Associated with Development, Metabolism and Reproduction in <i>Tribolium castaneum</i>. [PDF]

Int J Mol Sci
Li W, Sun Y, Liang Y, Wang Y, Fan Y, Li M, Sun R, Xie J.   +7 more
europepmc   +1 more source

The effects of early exercise on cardiovascular biomarkers in patients with congestive heart failure

ESC Heart Failure, EarlyView.
Abstract Background Exercise training improves functional outcomes in chronic heart failure (HF), but the effects of early in‐hospital physical activity on cardiovascular biomarkers and prognosis in acute congestive heart failure (AHF) patients remain unclear.
Yanxiang Sun, Xuansheng Huang, Bing Hu, Zidi Wu, Yanchun Zhang, Yong Yuan, Li Feng   +6 more
wiley   +1 more source

Elevated Troponin T (TnT) in Non-acute Coronary Syndrome (ACS) Due to Dermatomyositis. [PDF]

Cureus
Alnakhli AS, AlShaikh K, Al Saud A, Rahim O.   +3 more
europepmc   +1 more source

<b>THE CA²⁺-ACTIVATION PROFILE OF RABBIT FAST SKELETAL MYOFIBRILS IS NOT AFFECTED BY TROPONIN T </b><b>ISOFORMS </b>

, 1996
Masamitsu Hatakenaka
openalex   +2 more sources

Direct comparison of clinical decision limits for cardiac troponin T and I

Heart, 2016
D. Kimenai, R. Henry, C. V. D. van der Kallen, P. Dagnelie, M. Schram, C. Stehouwer, J. D. V. van Suijlen, Marijke Niens, O. Bekers, S. Sep, N. Schaper, M. V. van Dieijen-Visser, S. Meex   +12 more
semanticscholar   +1 more source

Pre‐admission beta‐blocker therapy and outcomes in cardiogenic shock: Insights from the Altshock‐2 Registry

ESC Heart Failure, EarlyView.
Among 668 with cardiogenic shock included in the multicentre prospective Altshock‐2 registry, 299 patients (44.8%) received pre‐admission beta‐blocker therapy. Previous beta‐blocker therapy influenced the early hemodynamic response to vasoactive drugs, but it was not associated with in‐hospital mortality.
Matteo Pagnesi, Mauro Riccardi, Alice Sacco, Giovanni Tavecchia, Giovanna Viola, Simone Frea, Martina Briani, Letizia Fausta Bertoldi, Maurizio Bertaina, Luciano Potena, Serafina Valente, Marco Marini, Gaetano Maria De Ferrari, Nicoletta D'Ettore, Astrid Cardinale, Rita Camporotondo, Matteo Rota, Guido Tavazzi, Nuccia Morici, Federico Pappalardo, Marco Metra, on behalf of the Altshock‐2 investigators   +21 more
wiley   +1 more source

A High-Sensitivity Troponin I Rapid Assay vs. a High-Sensitivity Troponin T Routine Assay in Acute Chest Pain Patients: A Prospective Monocentric Study. [PDF]

J Clin Med
Han E, Gyöngyösi M, Anwari E, Kokabi V, Gramser A, Spannbauer A, Fritzer-Szekeres M, Bergler-Klein J.   +7 more
europepmc   +1 more source

Cardiac troponin-T and diagnostic test evaluation [PDF]

, 1995
Ian Katz, L Wyndham, Les Irwig
openalex   +1 more source